Recro Pharma Net Profit Margin 2014-2020 | REPH

Recro Pharma net profit margin from 2014 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Recro Pharma Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-03-31 $0.10B $-0.03B -26.04%
2019-12-31 $0.10B $-0.02B -19.19%
2019-09-30 $0.10B $-0.05B -50.51%
2019-06-30 $0.09B $-0.06B -64.13%
2019-03-31 $0.08B $-0.07B -83.13%
2018-12-31 $0.08B $-0.08B -101.28%
2018-09-30 $0.08B $-0.06B -78.48%
2018-06-30 $0.08B $-0.06B -74.36%
2018-03-31 $0.07B $-0.05B -73.97%
2017-12-31 $0.07B $-0.05B -69.44%
2017-09-30 $0.07B $-0.04B -51.43%
2017-06-30 $0.07B $-0.03B -45.71%
2017-03-31 $0.07B $-0.03B -44.29%
2016-12-31 $0.07B $-0.03B -43.48%
2016-09-30 $0.07B $-0.01B -13.04%
2016-06-30 $0.07B $-0.01B -8.70%
2016-03-31 $0.07B $0.00B 1.41%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.104B $0.099B
Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain and neuropathic pain. Recro Pharma, Inc. is based in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.879B 38.52
Takeda Pharmaceutical (TAK) Japan $55.173B 9.67
Astellas Pharma (ALPMY) Japan $30.403B 15.41
UCB SA (UCBJF) Belgium $24.547B 0.00
Eisai (ESALY) Japan $23.444B 20.32
Merck (MKGAF) Germany $16.680B 21.87
Grifols, S.A (GRFS) Spain $13.380B 16.63
Catalent (CTLT) United States $12.966B 50.13
Neurocrine Biosciences (NBIX) United States $12.551B 58.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.340B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.770B 46.63
IPSEN SA ADR (IPSEY) France $7.793B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.421B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.058B 9.70
United Therapeutics (UTHR) United States $5.331B 10.10
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.903B 535.33
Nektar Therapeutics (NKTR) United States $4.389B 0.00
FibroGen (FGEN) United States $4.054B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
Hypermarcas (HYPMY) Brazil $3.708B 13.64
ChemoCentryx (CCXI) United States $3.675B 0.00
PTC Therapeutics (PTCT) United States $3.641B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.572B 10.57
Cronos Group (CRON) Canada $2.449B 70.20
Pacira BioSciences (PCRX) United States $2.421B 49.55
Sage Therapeutics (SAGE) United States $2.349B 0.00
Xencor (XNCR) United States $1.915B 0.00
Corcept Therapeutics (CORT) United States $1.893B 18.77
USANA Health Sciences (USNA) United States $1.824B 18.70
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.658B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.649B 12.62
Zogenix (ZGNX) United States $1.625B 0.00
Akebia Therapeutics (AKBA) United States $1.609B 0.00
Heron Therapeutics (HRTX) United States $1.558B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.488B 16.03
Indivior (INVVY) United States $1.465B 18.18
Karyopharm Therapeutics (KPTI) United States $1.418B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.389B 0.00
Esperion Therapeutics (ESPR) United States $1.354B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.195B 0.00
VAXART, INC (VXRT) United States $1.075B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.061B 47.37
Tilray (TLRY) Canada $0.979B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.922B 0.00
Endo (ENDP) Ireland $0.822B 1.27
ImmunoGen (IMGN) United States $0.804B 0.00
Trillium Therapeutics (TRIL) Canada $0.642B 0.00
Aerie Pharmaceuticals (AERI) United States $0.639B 0.00
Radius Health (RDUS) United States $0.612B 0.00
Collegium Pharmaceutical (COLL) United States $0.596B 0.00
Ardelyx (ARDX) United States $0.588B 0.00
Molecular Templates (MTEM) United States $0.580B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.553B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.525B 12.70
Flexion Therapeutics (FLXN) United States $0.519B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.513B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.505B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.490B 19.10
Ocular Therapeutix (OCUL) United States $0.447B 0.00
TherapeuticsMD (TXMD) United States $0.446B 0.00
DURECT (DRRX) United States $0.437B 0.00
Altimmune (ALT) United States $0.411B 0.00
Organogenesis Holdings (ORGO) United States $0.407B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.389B 0.00
Harpoon Therapeutics (HARP) United States $0.386B 0.00
Calithera Biosciences (CALA) United States $0.371B 0.00
MEI Pharma (MEIP) United States $0.371B 0.00
Taiwan Liposome (TLC) Taiwan $0.315B 0.00
Concert Pharmaceuticals (CNCE) United States $0.313B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.296B 0.00
IMV INC (IMV) Canada $0.268B 0.00
PROFOUND MEDICL (PROF) Canada $0.262B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.253B 0.00
Redhill Biopharma (RDHL) Israel $0.230B 0.00
KalVista Pharmaceuticals (KALV) United States $0.221B 0.00
Rafael Holdings (RFL) United States $0.219B 0.00
CASI Pharmaceuticals (CASI) United States $0.212B 0.00
OptiNose (OPTN) United States $0.211B 0.00
Lannett Co Inc (LCI) United States $0.207B 4.55
Nature's Sunshine Products (NATR) United States $0.195B 25.69
Jounce Therapeutics (JNCE) United States $0.180B 4.29
Nivalis Therapeutics (ALPN) United States $0.175B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.158B 0.00
Aquestive Therapeutics (AQST) United States $0.147B 0.00
Otonomy (OTIC) United States $0.132B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.125B 0.00
Heat Biologics (HTBX) United States $0.124B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.121B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.120B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.111B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
MediWound (MDWD) Israel $0.109B 0.00
Xeris Pharmaceuticals (XERS) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
CTI BioPharma (CTIC) United States $0.102B 0.00
Onconova Therapeutics (ONTX) United States $0.097B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.097B 0.00
Biomerica (BMRA) United States $0.095B 0.00
Sundial Growers (SNDL) Canada $0.094B 0.00
Hemispherx BioPharma (AIM) United States $0.092B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.087B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.068B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
PolarityTE (PTE) United States $0.066B 0.00
Lipocine (LPCN) United States $0.062B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
ElectroCore (ECOR) United States $0.059B 0.00
CV Sciences (CVSI) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.91
Addex Therapeutics (ADXN) Switzerland $0.049B 0.00
Natural Alternatives (NAII) United States $0.049B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.048B 0.00
Infinity Pharmaceuticals (INFI) United States $0.048B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.046B 0.00
Novan (NOVN) United States $0.043B 0.00
IsoRay (ISR) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.78
Opiant Pharmaceuticals (OPNT) United States $0.041B 86.73
Jaguar Animal Health (JAGX) United States $0.039B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.035B 0.00
GTx (ONCT) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.014B 32.84
Shineco (TYHT) China $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Vical (BBI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00